Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: the Cancer and Leukemia Group B study 9730. J Clin Oncol 23:190-6, 2005
Management Issues for Stage IV Non-Small-Cell Lung Cancer Craig C. Earle, MD, FRCPC, and William K ... They virtually never induce complete remissions (CRs), and single agents have little or no ...
Eli Lilly provides information on ALIMTA, approved as a single-agent for the treatment of non-small cell lung cancer and in combination with cisplatin by the FDA for the treatment of malignant pleural ...
Non-Small Cell Lung Cancer Lung cancer is the uncontrolled growth of malignant (cancerous) cells ... According to the American Cancer Society, lung cancer is the single largest cause of cancer deaths in ...